Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARGAN INCAGX · Entity 3828 | Chief Financial Officer | June 17, 2026 | June 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARGAN INC
Report date June 17, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,479 |
Ending reported balance
After 2026-06-17 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-06-17 · Exercise / conversion · Acquired 455 · Balance 2,239 F1: On June 17, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method. Row 2 · 2026-06-17 · Sale · Disposed 455 · Balance 1,784 F2: On June 17, 2026, the Reporting Person sold 455 shares of the Issuer's common stock on the open market at a price of $732.83 per share. Row 3 · 2026-06-17 · Sale · Disposed 305 · Balance 1,479 F3: On June 17, 2026, the Reporting Person sold 305 shares of the Issuer's common stock on the open market at a price of $734 per share. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $61.22 · Expires 2034-04-16 | Direct | 1,708 |
Reported balance
After 2026-06-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-17 · Exercise / conversion · Disposed 1,000 · Balance 1,708 F1: On June 17, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 17, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method.
F2: On June 17, 2026, the Reporting Person sold 455 shares of the Issuer's common stock on the open market at a price of $732.83 per share.
F3: On June 17, 2026, the Reporting Person sold 305 shares of the Issuer's common stock on the open market at a price of $734 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2026 Filed Jun 18, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionOption to Purchase Common Stock · Derivative | 1,000 | $61.22 Strike: $61.22 | $61,220.00 |
DisclosureSEC source: 0002066213-26-000010 · form4-06182026_050601.xml · derivative · entry 4 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,708 Underlying: Common Stock · 1,000 shares Expires 2034-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 17, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method. Read SEC document |
| June 17, 2026 Filed Jun 18, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 305 | $734.00 | $223,870.00 |
DisclosureSEC source: 0002066213-26-000010 · form4-06182026_050601.xml · nonDerivative · entry 3 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,479 F3 · shares: On June 17, 2026, the Reporting Person sold 305 shares of the Issuer's common stock on the open market at a price of $734 per share. Read SEC document |
| June 17, 2026 Filed Jun 18, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 455 | $732.83 | $333,437.65 |
DisclosureSEC source: 0002066213-26-000010 · form4-06182026_050601.xml · nonDerivative · entry 2 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,784 F2 · shares: On June 17, 2026, the Reporting Person sold 455 shares of the Issuer's common stock on the open market at a price of $732.83 per share. Read SEC document |
| June 17, 2026 Filed Jun 18, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 455 | $61.22 | $27,855.10 |
DisclosureSEC source: 0002066213-26-000010 · form4-06182026_050601.xml · nonDerivative · entry 1 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On June 17, 2026, the Reporting Person exercised a portion of his stock option awarded on April 16, 2024 to purchase 1,000 shares of the Issuer's common stock at a price of $61.22 per share using the net settle method. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 584 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002066213-26-000006 · form4-04202026_050403.xml · derivative · entry 7 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,459 Underlying: Common Stock · 584 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 584 shares of Common Stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. F4 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 584 shares of Common Stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. Read SEC document |
| April 17, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0002066213-26-000006 · form4-04202026_050403.xml · nonDerivative · entry 4 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 17, 2023, 584 shares of Common Stock became issuable to the Reporting Person on April 17, 2026 and is adjusted for dividends. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 667 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002066213-26-000006 · form4-04202026_050403.xml · derivative · entry 6 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,043 Underlying: Common Stock · 667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 667 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends. F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 667 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 1,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002066213-26-000006 · form4-04202026_050403.xml · derivative · entry 5 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,710 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 1,000 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends. F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 1,000 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | SaleCommon Stock | 600 | $605.60 | $363,360.00 |
DisclosureSEC source: 0002066213-26-000006 · form4-04202026_050403.xml · nonDerivative · entry 3 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,479 F3 · shares: On April 16, 2026, the Reporting Person sold 600 shares of the Issuer's common stock on the open market at an average price of $605.60 per share. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0002066213-26-000006 · form4-04202026_050403.xml · nonDerivative · entry 2 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to the three-year vesting schedule of the TRSUs awarded to the Reporting Person on April 16, 2025, 667 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 21:00 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 509 | $0.00 | $0.00 |
DisclosureSEC source: 0002066213-26-000006 · form4-04202026_050403.xml · nonDerivative · entry 1 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Units ("TRSUs") awarded to the Reporting Person on April 16, 2024, 1,000 shares of common stock became issuable to the Reporting Person on April 16, 2026 and is adjusted for dividends. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | GrantEarnings Per Share Performance-Based Restricted Stock Units · Derivative | 1,670 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002066213-26-000002 · form4-04102026_040401.xml · derivative · entry 4 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,420 Underlying: Common Stock · 1,670 shares Expires not disclosed F4 · derivative.exercise_date: On April 8, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 1,670 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 1,670 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period. F4 · derivative.expiration_date: On April 8, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 1,670 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2027, 2028 and 2029 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2024, 2025 and 2026. The pay-out ratio of the target number of 1,670 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | GrantPerformance-Based Restricted Stock Units · Derivative | 142 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002066213-26-000002 · form4-04102026_040401.xml · derivative · entry 3 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,642 Underlying: Common Stock · 142 shares Expires not disclosed F3 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 142 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 142 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period. F3 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 142 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2026 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 142 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 126 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002066213-26-000002 · form4-04102026_040401.xml · derivative · entry 2 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,710 Underlying: Common Stock · 126 shares Expires not disclosed F2 · derivative.exercise_date: On April 8, 2026, the Reporting Person was granted TRSUs covering 126 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027. F2 · derivative.expiration_date: On April 8, 2026, the Reporting Person was granted TRSUs covering 126 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/8/2027. Read SEC document |
| April 08, 2026 Filed Apr 10, 2026 20:30 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 208 | $0.00 Strike: $588.28 | $0.00 |
DisclosureSEC source: 0002066213-26-000002 · form4-04102026_040401.xml · derivative · entry 1 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,708 Underlying: Common Stock · 208 shares Expires 2036-04-08 F1 · shares: On April 8, 2026, the Reporting Person was granted a 10-year option to purchase 208 shares of the Issuer's common stock at an exercise price of $588.28 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/8/2027. Read SEC document |
| April 17, 2025 Filed May 6, 2025 21:16 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 583 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012112 · form4-05062025_090523.xml · derivative · entry 5 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,584 Underlying: Common Stock · 583 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on April 17, 2023, 583 shares of Common Stock became issuable to the Reporting Person on April 17, 2025. F2 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on April 17, 2023, 583 shares of Common Stock became issuable to the Reporting Person on April 17, 2025. F2 · derivative.underlying: Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on April 17, 2023, 583 shares of Common Stock became issuable to the Reporting Person on April 17, 2025. Read SEC document |
| April 17, 2025 Filed May 6, 2025 21:16 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 322 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012112 · form4-05062025_090523.xml · nonDerivative · entry 2 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,235 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Pursuant to the three-year vesting schedule of the TRSU awarded to the Reporting Person on April 17, 2023, 583 shares of Common Stock became issuable to the Reporting Person on April 17, 2025. Read SEC document |
| April 16, 2025 Filed May 6, 2025 21:16 UTC | ARGAN INC AGX · Entity 3828 | GrantEarnings Per Share Performance-Based Restricted Stock Units · Derivative | 3,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012112 · form4-05062025_090523.xml · derivative · entry 8 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires not disclosed F6 · derivative.exercise_date: On April 16, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 3,750 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2026, 2027 and 2028 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2023, 2024 and 2025. The pay-out ratio of the target number of 3,750 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period. F6 · derivative.expiration_date: On April 16, 2025, the Reporting Person was granted Earnings Per Share Performance-Based Restricted Stock Units ("EPSRSUs") in the target number of 3,750 shares, the vesting of which is subject to the sum of Earnings Per Share ("EPS") for fiscal years ending January 31, 2026, 2027 and 2028 compared to target compounded growth EPS amounts based on the sum of EPS for the fiscal years ended January 31, 2023, 2024 and 2025. The pay-out ratio of the target number of 3,750 shares, ranging from 0% to 200%, will depend on the degree of achievement of the EPS ranking at the end of the three-year performance period. Read SEC document |
| April 16, 2025 Filed May 6, 2025 21:16 UTC | ARGAN INC AGX · Entity 3828 | GrantPerformance-Based Restricted Stock Units · Derivative | 1,500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012112 · form4-05062025_090523.xml · derivative · entry 7 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires not disclosed F5 · derivative.exercise_date: On April 16, 2025, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 1,500 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2025 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 1,500 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period. F5 · derivative.expiration_date: On April 16, 2025, the Reporting Person was granted Performance-Based Restricted Stock Units ("PRSUs") in the target number of 1,500 shares, the vesting of which is subject to the rank of the Total Stock Return ("TSR") of the Issuer's common stock over a three-year period, as determined by the Issuer's Board of Directors, to the comparable TSRs of 12 peer public companies to be disclosed in the Issuer's 2025 Proxy Statement. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. The payout ratio of the target number of 1,500 shares, ranging from 0% to 200%, will depend on the degree of achievement of the TSR ranking. The determination of the number of shares of common stock to be issued shall occur at the end of the three-year performance period. Read SEC document |
| April 16, 2025 Filed May 6, 2025 21:16 UTC | ARGAN INC AGX · Entity 3828 | GrantOption to Purchase Common Stock · Derivative | 1,000 | $148.72 Strike: $148.72 | $148,720.00 |
DisclosureSEC source: 0001415889-25-012112 · form4-05062025_090523.xml · derivative · entry 6 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 1,000 shares Expires 2035-04-16 F4 · shares: On April 16, 2025, the Reporting Person received 10-year options to purchase 1,000 shares of the Issuer's common stock with an exercise price of $148.72 per share. The options will vest ratably over three years on each anniversary of the grant date starting on 4/16/2026. Read SEC document |
| April 16, 2025 Filed May 6, 2025 21:16 UTC | ARGAN INC AGX · Entity 3828 | GrantTime-Based Restricted Stock Units · Derivative | 2,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012112 · form4-05062025_090523.xml · derivative · entry 4 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,167 Underlying: Common Stock · 2,000 shares Expires not disclosed F3 · derivative.exercise_date: On April 16, 2025, the Reporting Person was granted TRSUs covering 2,000 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/16/2026. F3 · derivative.expiration_date: On April 16, 2025, the Reporting Person was granted TRSUs covering 2,000 shares of common stock. The TRSUs will vest in equal installments on each of the next three anniversaries of the grant date starting on 4/16/2026. Read SEC document |
| April 16, 2025 Filed May 6, 2025 21:16 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionTime-Based Restricted Stock Units · Derivative | 1,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012112 · form4-05062025_090523.xml · derivative · entry 3 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,167 Underlying: Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 1,000 shares of Common Stock became issuable to the Reporting Person on April 16, 2025. F1 · derivative.expiration_date: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 1,000 shares of Common Stock became issuable to the Reporting Person on April 16, 2025. Read SEC document |
| April 16, 2025 Filed May 6, 2025 21:16 UTC | ARGAN INC AGX · Entity 3828 | Exercise / conversionCommon Stock | 538 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012112 · form4-05062025_090523.xml · nonDerivative · entry 1 Baugher Joshua Scott · CIK 0002066213 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Pursuant to the three-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on April 16, 2024, 1,000 shares of Common Stock became issuable to the Reporting Person on April 16, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.